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The term nanomaterial encompassesa variety of materials with nanoscalestructural features which include
nanoparticles, nanoﬁbers, nanosurfaces, and
nanocomposites. As nanomaterials become
increasingly more sophisticated in their
range of physical properties (2D surfaces,
3D structures, variable porosity, stiﬀness,
and biodegradability), their diversity of use
for medical applications continues to ex-
pand. Both physical and chemical proper-
ties of biomaterials are now more readily
altered, providing opportunities to improve
eﬃcacy.1
Stem cells can be isolated from a variety
of sources and consequently diﬀer in their
ease of in vitro culture, proliferation rates,
and capacity to form specialized cell types.
Regardless of stem cell type, current focus
remains on stem cell expansion, mainte-
nance of the stem cell state, diﬀerentiation,
and, ultimately, transplantation and clinical
application. Enhanced understanding and
manipulation of stem cells to produce cell
types of interest or transplantable tissues is
the predominant goal of regenerative
medicine. Here we restrict predominantly
to investigations of nanoscale physical
properties and their use in embryonic stem
cell (ESC) and ESC-like-induced pluripotent
stem cell (iPSC) research. Furthermore,
we assess how nanomaterials may hold
the key for future advances in regenerative
medicine.
Embryonic Stem Cells and Induced Pluripotent
Stem Cells. Derivation and Properties. ESCs
are isolated from the inner cell mass (ICM)
of blastocyst stage embryos (Figure 1).
In vivo, the ICM develops to form ectoder-
mal, endodermal, and mesodermal tissues
of the embryo proper. ESCs exhibit the
unique property of pluripotency, the ability
to form any specialized, differentiated cell
types of the organism from which they are
derived. Hence, ESCs can differentiate to
form any cell type of the adult organism
(Figure 1). In order tomaintain pluripotency,
ESCs must proliferate while suppressing
differentiation, a process known as self-
renewal.
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ABSTRACT Embryonic stem cells (ESCs) and induced pluripotent stem cells
(iPSCs) have the capacity to diﬀerentiate into any specialized cell type of the
human body, and therefore, ESC/iPSC-derived cell types oﬀer great potential for
regenerative medicine. However, key to realizing this potential requires a strong
understanding of stem cell biology, techniques to maintain stem cells, and
strategies to manipulate cells to eﬃciently direct cell diﬀerentiation toward a
desired cell type. As nanoscale science and engineering continues to produce novel
nanotechnology platforms, which inform, inﬁltrate, and impinge on many aspects
of everyday life, it is no surprise that stem cell research is turning toward developments in nanotechnology to answer research questions and to overcome
obstacles in regenerative medicine. Here we discuss recent advances in ESC and iPSC manipulation using nanomaterials and highlight future challenges
within this area of research.
KEYWORDS: embryonic stem cells . nanomaterials . nanoparticles . nanotopography . regenerative medicine . niche
REV
IEW
KINGHAM AND OREFFO VOL. 7 ’ NO. 3 ’ 1867–1881 ’ 2013
www.acsnano.org
1868
In 1981, the ﬁrst ESCs, derived from mice (mESCs),
were isolated and grown in culture.2 Almost two
decades later, the isolation of human ESCs (hESCs)
was reported by Thomson and colleagues.3 For mouse
or human ESCs, pluripotency is demonstrated by in-
jection into immune-deﬁcient mice to produce terato-
mas containing cells expressing markers of each of the
three primary germ layers.3,4 Pluripotency of mESCs
can also be demonstrated by injection into a mouse
blastocyst to form a chimeric mouse and subsequent
assessment of oﬀspring to conﬁrm incorporation of
these cells into the germline.5 However, the conditions
required formaintaining pluripotency and self-renewal
of mESC and hESCs in vitro are quite diﬀerent, and thus
studies in one animal ESC line are not always transfer-
able to another.
While adult stem cells are ethically preferable,
sources of humanadult stemcells are somewhat limited,
and isolation can prove complex and can be painful for
the patient. The limited capacity of adult stem cells to
self-renew makes their expansion in vitro a signiﬁcant
challenge, and unlike hESCs, adult stem cells are lineage
restricted. Evidence exists to suggest that hESC-derived
cell populations display low immunogenicity and could,
potentially, be transplanted with minimal immuno-
suppression.68 Similarly, mesenchymal stem cells and
indeed hESC-derived mesenchymal stem cells are also
reported to provide immunosuppressive properties.9,10
Consequently, ESCs oﬀer signiﬁcant potential to treat a
wider range of diverse pathological disorders.
Adult somatic cell-derived iPSCs are increasingly
being investigated as a patient-speciﬁc alternative to
hESCs with less controversy. Seminal papers from the
Yamanaka group demonstrated that mouse ﬁbroblasts
could be reprogrammed to mESC-like cells by the ex-
pression of four mESC-speciﬁc transcription factor genes
(Klf4, c-Myc, Oct-3/4, and Sox2).11,12 More recently, adult
human ﬁbroblasts have been geneticallymanipulated to
form human iPSCs.13,14 Since these initial publications,
further reports describe iPSCs formed from nonpluripo-
tent, somatic adult cells, and additional strategies have
been developed to limit genetic manipulation or to
incorporate reprogramming factor-free methods.15 Criti-
cally, a highdegree of similarity exists between iPSCs and
ESCs, oﬀering new hope for the use of pluripotent stem
cells for regenerative therapies with fewer ethical con-
cerns and, potentially, enhanced patient speciﬁcity.1618
VOCABULARY:Nanomaterials - share the deﬁning char-
acteristic of feature size within the nanoscale range of
1100 nmbut can bemade ofmetals, ceramics, polymers,
or composite materials and include nanoparticles, nano-
ﬁbers, nanosurfaces, and nanocomposites.;Nanotopo-
graphy - the roughness or spatial features displayed by
a surface with nanoscale dimensions.;Niche - the in vivo or
in vitro environment which provides both chemical and
physical cues to maintain self-renewal or to direct diﬀer-
entiation.;Pluripotency - the ability of a stem cell to form
any specialized, diﬀerentiated cell types of the organism
from which it is derived.;Regenerative Medicine - the
replacement or regeneration of cells or tissues to repair or
replace aged, diseased, or injured tissue.; Self-renewal -
encompasses the proliferation of stem cells while main-
taining the stem cell state.;
Figure 1. Derivation of human ESC lines and their pluripotency ESC lines are derived from the inner cell mass of blastocyst
stage embryos and, when maintained in culture, undergo self-renewal, proliferation with retention of the stem cell state.
In vitro, these cells are pluripotent in their ability to diﬀerentiate to any cell type of the three germ layers (endoderm,
ectoderm, and mesoderm) that comprise the embryo proper. Theoretically, embryonic stem cells could be manipulated to
form any cell type of the human body, but in reality, this requires a detailed understanding of the chemical and physical cues
necessary to direct diﬀerentiation to a speciﬁc cell type.
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Therapeutic Potential. It is the property of pluripo-
tency, the possibility of producing any of the cell types
that comprise the human body, to which hESCs and
human iPSCs owe their therapeutic and research
potential. Within the field of regenerative medicine,
significant focus is placed on the expansion of ESC/
iPSCs and directed differentiation into homogeneous
cultures ex vivo, followed by transplantation. In this
sense, ESC/iPSC-derived cell types would be trans-
planted with the view to repairing or replacing cells
lost or damaged through disease and injury for regen-
erative medical strategies. However, the concept of
regenerative medicine has been expanded beyond
purely the use of ESC-derived cell types and tissue
structures. Genetic manipulation prior to transplanta-
tion may not only reduce the risk of rejection but
transplanted cells may also provide a novel vehicle
for gene therapy to treat genetic diseases and cancer.19
Furthermore, ESC/iPSC-derived cell types may prove to
be a valuable source of cells on which to test new
candidate drugs, an enterprise that has previously
relied on animal models, limited human cell lines,
and human volunteers. Thus drug toxicity testing
and candidate drug screening on ESC/iPSC-derived
cell types could significantly benefit from this area of
research.20
The therapeutic potential of hESCs and iPSCs is vast;
however, to realize this essentially requires mass ex-
pansion of a homogeneous, self-renewing, pluripotent
population of cells to obtain suﬃcient cell numbers,
followed by eﬃcient speciﬁc diﬀerentiation to a de-
sired precursor or terminally diﬀerentiated cell type
prior to clinical application. For iPSCs, in addition to
these challenges, the eﬃcient induction of pluripo-
tency in adult cells without compromising safety
by genetic manipulation that might result in greater
risk to the patient subsequent to reintroduction of cells
must also be overcome.
Stem Cell Niche. The stem cell niche is the cellular
and non-cellular environment surrounding stem cells
and can comprise both chemical (soluble) and physical
(nonsoluble or topographical) features of micro- and
nanoscale proportions. Through interaction with this
niche, stem cell fate is regulated. It is widely accepted
that establishment of a stem cell niche is important
both to maintain the population of stem cells and to
provide an environment for the differentiation of stem
cells into specialized cell types for contribution to
functional tissues.21,22 Just as a cell detects the chemi-
cal components of its environment including proteins,
hormones, and growth factors, the physical properties
of the surroundings can also influence cell fate. In vivo,
the physical environment is provided by the extra-
cellular matrix (ECM) with varying degrees of stiffness
and topographical features depending on the stem-
cell-specific niche. Similarly, in vitro, factors such as
mechanical properties, surface stiffness, chemistry, and
nanotopography have all been reported to influence
stem cell maintenance and lineage commitment.2332
Directed diﬀerentiation protocols involve the
addition or removal of factors to culture media in a
sequential manner.33 This approach serves to activate
or inhibit intracellular signaling pathways in a temporal
fashion to induce changes in gene expression, driving
cell diﬀerentiation down a speciﬁc lineage. In vivo
diﬀerentiation is a complex process requiring both
chemical and physical cues (both temporally and
spatially), whereas standard chemical-induced meth-
ods neglect the importance of the physical environ-
ment experiencedby a cell. Thus, in vitro techniques for
directed diﬀerentiation combining chemical cues and
topographical cuesmay bemore eﬃcient and allow for
the production of a wider range of cell types. In the ﬁrst
instance, an understanding of cell type and character-
istics is informative in any niche development.
Nanomaterials. Nanomaterials for ESC Research and
Regenerative Medicine. Early approaches using nano-
materials predominantly focused on adult terminally
differentiated or adult stem cell types and implemen-
ted surfaces displaying nanoscale topography that
mimicked the ECM. Collagen is a major component
of the ECM, and nanoscale collagen fiber structures
were found to enhance the cellmatrix interaction.34
Furthermore, there are several publications describing
the successful replacement of feeder cells with extra-
cellular matrix components in order to support self-
renewal or to promote differentiation of ESCs.3539
Subsequently, synthetic nanoscale surfaces and scaf-
folds have been used to investigate the contribution
of niche topography to maintain the stem cell state or
to direct differentiation in the absence of chemical
factors. Protocols for directed differentiation have
applications for the derived cell types in drug toxicity
screening and regenerative medicine.
Due to continual advances in fabrication methods,
nanomaterials are developing with a strong regenera-
tive medicine focus (reviewed in ref 40 and references
therein). Speciﬁcally, nanomaterials have been imple-
mented to address surface molecule tracking and
in vivo tracking of transplanted cells, while nanoparti-
cles have been investigated for their potential to
deliver molecules (DNA, RNAi, protein) intracellularly.
Intracellular Delivery to ESCs or Somatic Cells Using
Nanomaterials. The genetic reprogramming of so-
matic cells toward a stem-cell-like state has garnered
considerable attention and has the remarkable poten-
tial to overcome both the limitations of adult stem
cells and the ethical issues surrounding ESC use. Of
the currently used methods, viral transfection of genes
is less desirable due to the safety concerns related to
genome-integrating viral DNA, while nonviral lipid or
polymer transfection agents often yield lower percen-
tages of successfully transfected cells.41 Nanoparticle
transfer of genetic material resolves these issues, and
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the range of nanoparticles available may allow this
method to be optimized to a higher efficiency than
other gene delivery methods.
Ferreira et al. demonstrated the internalization and
perinuclear accumulation of PLGAnanoparticleswithin
hESC colonies and aggregated hESCs forming embry-
oid bodies (EBs). Importantly, no adverse eﬀects on
cell viability or proliferation were reported in cells
containing nanoparticles.42 Focusing on gene delivery,
Kutsuzawa et al. demonstrated that nanoparticles
formed of carbonate apatite crystals mixed with cell
adhesive proteins ﬁbronectin and E-cadherin-Fc en-
hanced transgene delivery and accelerated expression
in recipient mESCs compared to carbonate apatite
alone.43,44 These mixed organic and inorganic nano-
particle composites bind to the cell surface and be-
come internalized by mESCs, providing an eﬃcient
nonviral method of gene delivery.44,45 Green et al.
reported the development and use of self-assembling,
biodegradable nanoparticles of poly(β-amino esters)
that incorporate plasmid DNA within the nanoparticle
for successful, higher eﬃciency transfection of hESCs.
Transfected hESCs reportedly maintained their viabili-
ty, undiﬀerentiated state, and pluripotency following
transfection with nanoparticles.46 The authors noted
thatmodiﬁcation of the endgroup of the polymer used
to form the nanoparticles altered the size and positive
ζ-potential of the nanoparticles with a resultant impact
on transfection eﬃciency46 and, critically, the potential
for cell-speciﬁc polymer modiﬁcation to modulate
transfection eﬃciency in undiﬀerentiated hESCs com-
pared to human umbilical vein cord cells.46,47 More
recently, nanomaterials have been reported to aid
reprogramming in the preparation of iPSCs. Thus
polyamidoamine dendrimer-modiﬁed magnetic nano-
particles were reported to enhance the delivery of
lentivirus expression plasmids and to induce the re-
programming of human dermal ﬁbroblasts to pluripo-
tent cells.48 Furthermore, Lee et al. reported eﬃcient
induction of pluripotency in mouse ﬁbroblasts using
biodegradable cationic polymer PEI-coated superpar-
amagnetic nanoparticles to produce transient expres-
sion of four ESC transcription factors.49 Consequently,
this magnetic nanofection technique led to over 60%
of the resultingmouse iPSC population being free from
integrated exogenous DNA.
Tracking Transplanted Cells with Nanoparticles. Nano-
particle labeling of ESCs prior to transplantation
into animal models offers a unique insight into cell
migration. Furthermore, nanoparticle trackingmay also
allow an assessment of the functional contribution to
replacing lost cells or to the repair of the diseased state.
Thus, by transfecting mESCs with superparamagnetic
dextran-coated iron oxide nanoparticles followed by
transplantation into rat brains, Hoehn and co-workers
were able to track mESC migration to a site of transient
cerebral ischemic lesion, performed 2 weeks previously
(Figure 2A).50 Interestingly, migration of labeledmESCs,
usingmagnetic resonance imaging (MRI), was observed
over an 11 day period from the site of implantation to
the opposite brain hemisphere where the lesion had
been performed. During this time, the morphology of
migrated mESCs had altered to neural-like cells in
contrast to the rounded morphology of mESCs at
the implantation site (Figure 2A).50 Arai et al. used a
superparamagnetic iron oxide agent to label mESCs
prior to injection into a murine model of acute myo-
cardial infarction and showed partial restoration of
left ventricular volume end fraction and a reduction
in thinning of the anterior and anterolateral region of
the myocardium in comparison to non-mESC-treated
mice.51 Importantly, neither study reported adverse
effects following mESC labeling with these nanopar-
ticles, with Hoehn et al. describing no distinguish-
able toxic or proliferation effects to the cells treated
with dextran-coated iron oxide nanoparticles and
Arai et al. reporting a nanoparticle-independent
ability of mESCs to partially restore myocardium
function in this model.50,51 Additionally, the uptake
of iron oxide nanoparticles did not affect the cardio-
genic or calcium handling capacity of mESC-derived
cardiomyocytes.52
The application of nanoparticles for medical appli-
cations holds signiﬁcant challenges since the chemical
composition of the nanoparticle can impact toxicity.
For example, silver nanoparticles were reported to
induce apoptosis and enhance expression of cell
cycle checkpoint protein p53 and DNA damage repair
protein Rad51 in mESCs.53 Silica nanoparticles were
reported to inhibit diﬀerentiation to contractile
myocardial cells in mouse EBs at concentrations at
which cytotoxic eﬀects were not observed in a test
typically used to assess the embryotoxic potential of
chemicals.54 Polystyrene nanoparticles were reported
to reduce mESC viability and enhance ﬁbroblastic
columnar cell-type morphologies.55 These studies
highlight not only the importance of adequate testing
of nanoparticles in relation to cell proliferation and
diﬀerentiation potential but also the possible deleter-
ious long-term eﬀects that nanoparticle accumulation
could have on patients receiving nanoparticle-based
therapies.56,57 Furthermore, maternalfetal risks asso-
ciated with nanoparticles and the potential for nano-
particle accumulation to transfer cumulatively to oﬀ-
spring are areas that clearly should also be addressed
(an excellent review on nanotoxicology is provided in
ref 58). However, these challenges may be overcome
by the implementation of biodegradable nanoparticles
suchas those championedbyGreenandcolleagues.46,47
Quantum dots are nanoscale particles with sus-
tained ﬂuorescence and good cellular uptake. The
ability to detect quantumdotﬂuorescenceby a number
of methods including in vivo detection allows biodis-
tribution following transplantation to be scrutinized.59
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Quantum dots have been used to successfully label
mESCs, with minimal eﬀects on viability and prolifera-
tion, and to visualize these cells within mice following
transplantation (Figure 2B).60 However, quantum dots
are manufactured in the presence of heavy metals
and exhibit a blinking phenomenon when visualized.
To overcome the limitations of quantum dots, Nagesha
et al. demonstrated that gold nanoparticles, detected
by multiphoton absorption-induced luminescence
(MAIL), could be used to visualize mESCs and, by
altering the plane of focus, could discriminate them
from their mouse embryonic ﬁbroblast feeder layer
of cells.61 Providing further hope for the tracking of
transplanted cells, iPSCs were successfully labeled with
ﬂuorescent magnetic silica coated quantum dots by
Ruan et al.48 (Figure 2C). Furthermore, iPSCs (derived
from human dermal ﬁbroblasts) retained their ﬂuores-
cent signal up to one month after labeling, indicating
suitability for longer term detection.48 These ﬁndings
demonstrate both the usefulness of nanoparticle track-
ing of ESCs and iPSCs and for the evaluation of the
regenerative capacity of ESCs.
Toward the Generation of a NanomaterialESC
Niche. Self-Renewal and Proliferation-Promoting
Figure 2. Quantum dot labeling for embryonic and induced pluripotent stem cell tracking. (A) Dextran-coated iron oxide
nanoparticles were used to label mESCs for detection by magnetic resonance imaging (MRI). Two weeks after transient focal
cerebral ischemia in Wistar rats, labeled cells were implanted into the normal contralateral hemisphere. Cells were observed to
migrate from the normal hemisphere to the lesioned hemisphere and line the ventricular wall (left) and accumulate in the
choroidplexus of the lateral ventricle (middle). Additionally,mESCswithin theperipheryof the ischemic lesion adopted a neural-
like morphology (right). Reprinted with permission from ref 50. Copyright 2002 National Academy of Sciences, U.S.A. (B)
Quantum dots emitting light of various wavelengths were used for intracellular labeling of mESCs prior to subcutaneous
injection of athymic nude mice. The ﬂuorescent signals emitted following a single excitation wavelength were detected by
imaging, shown as a stacked image (left). Fluorescent signal intensity for each quantum dot was quantiﬁed and is represented
graphically as total signal background/exposure time (ms) (right). Reprintedwithpermission fromref 60.Copyright2007BioMed
Central. (C) Human dermal ﬁbroblasts were reprogrammed to iPSCs and fully characterized (bright-ﬁeld image of iPSCs shown
left). Using ﬂuorescent magnetic nanoparticles (FMNPs), iPSCs were labeled, and after 4 h, ﬂuorescence was detected
intracellularly (right). Reprinted with permission from ref 48. Copyright of 2011 Dove Medical Press Ltd.
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Nanomaterials. One strategy for the generation of a
nanomaterialESC niche has centered on the devel-
opment of proliferation-promoting scaffolds for ESCs.
Differentiated cell types typically display slower pro-
liferation rates compared to ESCs, and large numbers
of cells would be required for medical applications,
emphasizing the need to expand ESCs prior to differ-
entiation. For example, Ultra-Web, a commercially
available 3D nanofibrillar scaffold with a nanoporous
matrix formed by electrospinning polyamide fibers
onto glass or plastic coverslips produces larger mESC
colonies which reportedly exhibit enhanced prolifera-
tion when grown on an Ultra-Web scaffold.62 Addition-
ally, the expression of Nanog protein, a marker of
self-renewal and an important regulator of the undif-
ferentiated state, was greater in mESCs cultured on
Ultra-Web compared with mESCs cultured on non-
Ultra-Web-coated coverslips.62 Interestingly, Nur-E-
Kamal et al. also reported on the activation of intra-
cellular signaling downstream of phosphoinositide
3-kinase (PI3K) inmESCs cultured on Ultra-Web-coated
coverslips. The PI3K signaling pathway is reported to
maintain mESC self-renewal and to regulate Nanog
expression6365 and is known to be important for
mESC proliferation,66,67 explaining the findings ob-
tained by Nur-E-Kamal and colleagues. A topographi-
cal surface formed from silica colloidal crystal (SCC)
microspheres with diameters of 120, 400, and 600 nm
with a type I collagen coatingwas reported tomaintain
the expression of mESC self-renewal markers in com-
parison to flat glass.68 Colonies of mESCs on micro-
sphere topographies were also reported to form a
central pit within the colony and exhibited reduced
spreading. Carbon-based materials provide a unique
alternative to organic polymeric nanomaterials and
have been implemented in pluripotent stem cell re-
search. Thus, for example, mouse iPSCs cultured on
graphene-coated glass surfaces exhibited a restricted
loss of Oct4 and Nanog expression in the absence of
self-renewal maintaining leukaemia inhibitory factor
(LIF) compared to graphene-oxide-coated glass or
uncoated glass surfaces.69
FGF-2, known to be essential for themaintenance of
hESC self-renewal,3,37,70,71 covalently linked to poly-
amide nanoﬁbrillar surfaces was reported to enhance
the proliferation of a number of cell types including
hESCs when compared to amine bound to nanoﬁbrillar
surfaces,72 although no assessment was made with
regards to hESC self-renewal marker expression (i.e.,
retentionof an undiﬀerentiated state). In the absence of
FGF, hESCs were observed to align along poly(dimethyl
siloxane) and ﬁbronectin grooves of 600 nm depth,
600 nm width, and 600 nm spacing. Adhesion and
contact guidance to this topography resulted in re-
duced cell surface area, greater elongation, and a
decreased rate of proliferationwhich could be reversed
by disruption of the actin cytoskeleton (Figure 3A).73
A comparison of biomaterials, extracellular matrix
components, and human-derived feeder cells to ﬁnd a
more eﬃcient platform for hESC expansion concluded
that the commonly usedMatrigel wasmost supportive
for long-term feeder-free culture.74 Subsequent to
this, vitronectin-coated nanorough glass surfaces have
been used to demonstrate diﬀerential adhesion of
hESCs and spontaneously diﬀerentiated hESCs demon-
strating topographical sensing and selectivity. hESCs
expressing the self-renewal marker OCT-4 selectively
adhered to regions of smooth surface over nanorough
regions (Figure 3B), displayed many ﬁlipodia, and
exhibited enhanced proliferation rates, whereas cells
with reduced expression of OCT-4 correlated with loss
of selectivity of surface roughness.75 More recently, a
synthetic polymer coating of poly[2-(methacryloyloxy)-
ethyl dimethyl-(3-sulfopropyl)ammonium hydroxide]
(PMEDSAH) was reported to maintain the prolifera-
tion, self-renewal, and pluripotency of two hESC lines
in mouse embryonic ﬁbroblast (MEF)-conditioned
media.76 Moreover, the observation that one of the cell
lines could be passaged up to 10 times in commercially
available serum-free deﬁned media on this PMEDSAH
surface is a signiﬁcant advancement in achieving scal-
able expansion of hESCs for biomedical applications.76
Recent approaches have also implemented the func-
tionalization of synthetic polymer coatings with bioac-
tive components. For example, Klim et al.demonstrated
that heparin-binding peptide derived from vitronectin
supported adhesion, propagation, karyotype, and
self-renewal marker expression through interaction
with surface glycosaminoglycans for a number of hESC
and human iPSC lines.77 Similarly, synthetic peptide-
acrylate surfaces were also reported to support hESC
maintenance.78 Crucially these latter studies utilized a
variety of readouts to characterize cells and conﬁrmed
pluripotency following an extended number of
passages. Additional investigation of the nanotopo-
graphical features provided by these coatings both in
combination with and dissociated from the chemical
interaction bioactive functionalization provide and in
comparison to Matrigel will inform future develop-
ments in this area.
For applications in regenerative medicine, it is
important that cell pluripotency is retained at the
expansion stage. It was demonstrated that mESCs
cultured on the 3D nanoﬁbrillar scaﬀold could be
induced to express neural markers in response to
retinoic acid treatment; however, other lineages were
not addressed.62 Furthermore, while OCT-4 expression
was reported to be retained by hESCs on a smooth
glass surfaces, other self-renewal markers were not
investigated and pluripotency was not assessed.75
For future applications, it would be imperative to fully
characterize cells following expansion on nanomater-
ials to conﬁrm not only pluripotency (by the methods
described in section Embryonic Stem Cells and
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Induced Pluripotent Stem Cells, Derivation and
Properties) but also karyotype, proliferation, and viabi-
lity among other requisite characteristics. These stud-
ies demonstrate a unique opportunity to combine
physical and chemical characteristics to inform and,
critically, recreate the ICM environment of the blasto-
cyst and generate an in vitro stem cell niche supportive
of self-renewal, expansion, and retention of pluripo-
tency.Nanomaterial-Induced ESC-Directed Diﬀerentia-
tion. Following expansion of hESCs, platforms eﬃcient
at inducing diﬀerentiation are required to reduce
the risk of transplanting undiﬀerentiated hESCs into
patients, a process that would result in teratoma
formation. The notion that physical, topographical
features can inﬂuence cell fate is not a new area
of research79,80 with seminal observations dating al-
most 50 years; rather, more novel is the concept that
nanoscale platforms can serve as feeder-free, animal-
product-free, and supplementary factor-free scaﬀolds
for directed stem cell diﬀerentiation.
Neural Differentiation. Neural-directed differentiation
protocols typically rely on induction of differentiation
following the aggregation of ESC to form EBs and the
addition of retinoic acid to culturemedia.8183 Xie et al.
successfully directed the differentiation of mESCs
by this method, then transplanted EBs on to bio-
degradable poly(ε-caprolactone) (PCL) nanofibers.
The authors observed migration of neural type cells
Figure 3. hESCs sense and respondmorphologically andphenotypically to nanoscale topographical cues. (A) hESC alignment
along poly(dimethyl siloxane) grooves with ﬁbronectin coating (upper panel) is reversed by disruption of the actin
cytoskeleton with cytochalasin D (Cyto D) or latrunculin B (Latr B) (lower panel)73 (scale bars 10 μm). Reprinted with
permission from ref 73. Copyright 2007 Elsevier. (B) SEM images of glass surfaces untreated (upper) and treated (middle and
lower) with a nanoroughening reactive ion etching technique. hESCs expressing OCT3/4 exhibited preferential attachment
and aggregation to smooth regions of glass over nanorough regions of glass.75 Reprinted with permission from ref 75.
Copyright 2012AmericanChemical Society. (C) Alignedpolymer nanoﬁberswere preparedby electrospinning (upper image).
These nanoﬁbers provided a suitable scaﬀold to guide the outgrowth of neurites frommESC EBswhich stain positive for early
neural marker Tuj1 (lower image).84 Reprinted with permission from ref 84. Copyright 2009 Elsevier. (D) Increased calcium
mineralization was detected on nanoﬁbrous ﬁlms seeded with mESC-EBs compared to solid walled or control scaﬀolds.100
Reprinted with permission from ref 100. Copyright 2009 Elsevier.
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(evidenced by the expression of early neural, oligo-
dendrocyte, and astrocyte markers) from EBs along
the axis of aligned nanofibers (Figure 3C).84 Neural
differentiation and cell migration on nanofibers were
also observed for mESCs seeded directly onto the PCL
nanofibers without prior EB formation, although these
cells formed aggregates on the nanofibers and retinoic
acid was added to the culturemedia, making it difficult
to distinguish the effects of nanofibers alone.84 Kabiri
and colleagues seeded EBs, derived frommESCs in the
presence of retinoic acid, onto an electrically conduc-
tive composite of carbon nanotubes and electrospun
poly(L-lactic acid) nanofibers reporting differential
neural marker gene expression dependent on the
presence of single- or multiple-walled nanotubes.85
Consistent with the mESC studies, seeding onto thin
film scaffolds based on carbon nanotubes, hESC-
derived EBs were reported to have increased neural
marker expression and enhanced adhesion,86 while
seeding onto a silk-carbon nanotube composite en-
hanced neural marker expression and enhanced
axonal length compared to silk alone.87 In the absence
of EB formation or retinoic-acid-induced differentia-
tion, hESCs seeded directly onto a composite of type I
collagen, and carbon nanotubes exhibited enhanced
nestin expression and ectodermal cell morphology
compared to cells seeded onto pure collagen matrix.
Nestin expression was greatly enhanced compared to
spontaneously differentiated cells seeded on gelatin.88
Furthermore, differentiated cells were aligned in the
direction of the collagen/carbon nanotube fibrils,88
indicating that spatial growthanddifferentiationof hESCs
can be directed using nanomaterials in the absence of
chemical factors or specific differentiation medium.
Ridges and grooves of nanoscale proportions
(350 nm spacing and 500 nm height) were reported
to be suﬃcient to induce neural diﬀerentiation of
hESCs. Although the nanotopography surfaces re-
quired gelatin coating and treatment with oxygenated
plasma to improve hESC adhesion, hESCs clearly
aligned in the direction of the grooves and stained
positive for a number of neural markers.89 Moreover,
nanotopography-induced diﬀerentiation required no
additional factors or the formation of EBs prior to
seeding, indicating that adhesion to these nano-
topography surfaces and removal of FGF from culture
media was suﬃcient to induce neural diﬀerentiation.89
However, within the ESC ﬁeld, it is argued that neural
diﬀerentiation may be the default diﬀerentiation
model of ESCs cultured without extrinsic cues to
diﬀerentiate toward other lineages.90,91 In keeping
with this model, non-neural lineage diﬀerentiation
would require alternative topographical features or a
combined approach of nanotopography and chemical
induction.
Surface Stiffness and Mesenchymal Directed Differ-
entiation. Engler et al. reported that a tight or loose
attachment of multipotent stem cells, depending on
the surface stiffness, can influence the lineage toward
which stem cells differentiate.25 In an investigation
using polyelectrolyte films, ESCs were also shown to
respond to stiffness.92 Multilayered films of poly-
(L-lysine) and hyaluronan that hold fewer cross-links
(and thus less stiff) were demonstrated to correlate
with reduced mESC proliferation compared to that
observed for either highly cross-linked nanofilms or
typical culture on gelatin-coated tissue culture plastic.92
Similarly, stiffer polydimethylsiloxane substrates of
1.92.7 MPa yielded greater numbers of mESCs after
6 days than less stiff polydimethylsiloxane substrates of
0.041 and 0.26 MPa.93
The expression of mESC markers Nanog, Sox2, and
Oct-4 were unaﬀected by the surface stiﬀness of poly-
(L-lysine) and hyaluronan.92 However, a reduction in the
expression of ICM marker genes Rex1, Stella, and Tbx3
was observed on all nanoﬁlms in comparison to sus-
pension culture, indicating a switch akin to the epiblast
stage. In terms of ESC diﬀerentiation, mesodermal
markers Brachyury and Goosecoid expression levels
were observed to be enhanced by culture of mESCs
on nanoﬁlms compared to either culture on non-cross-
linked nanoﬁlm or suspension culture.92 Similarly,
culture of mESCs on stiﬀer polydimethylsiloxane sub-
strates enhanced the expression of primitive streak
and mesendodermal markers, Brachyury, Mixl1, and
Eomes.93 Consistent with the expression of early diﬀer-
entiation markers, adhesion to stiﬀ nanoﬁlms prior to
EB formation resulted in impaired EB diﬀerentiation
potential. Hayashi and colleagues suggested that poly-
(L-lysine) and hyaluronan nanoﬁlms directed mESCs
toward an epiblast fate, a developmental progression
from ICM, between which mESCs are thought to cycle
in culture,94 although a low level of poly(L-lysine) and
hyaluronan was detected to be released from nano-
ﬁlms into the culture media. Furthermore, when free
poly(L-lysine) or free poly(L-lysine)/hyaluronan com-
plexes were added to cultures on gelatin-coated
plates, mESCs showed a down-regulation of Brachyury
expression, indicating a chemical inﬂuence of poly-
(L-lysine) on retaining a stem cell state.92 By investigat-
ing the stiﬀness of cells through application of stress to
the cell surface and assessment of cell deformation,
Chowdhury et al. demonstrated that undiﬀerentiated
mESCs were softer and exhibited greater spreading
in response to local cyclic stress compared to diﬀer-
entiated mESCs.95 Furthermore, cyclic stress resulted
in reduced expression of Oct-3/4 in the targeted cell.
In a subsequent study, Chowdhury and co-workers
report that matching the softness of the substrate
to mESC softness promoted self-renewal in the ab-
sence of LIF for up to 5 days.96 In contrast, hESCs
bound and formed more robust colonies that re-
mained attached when presented with stiﬀer (10 kPa)
hydrogels, functionalized with glycosaminoglycans or
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Matrigel, compared to less stiﬀ equivalents (0.7 and
3kPA).97
Using EB formation to induce diﬀerentiation of
mESCs, Garreta et al. demonstrated enhanced osteo-
genic diﬀerentiation as determined by enhanced
osteopontin expression and mineralization of EB-
derived cells on a 3D nanoﬁber peptide scaﬀold in
the presence of osteogenic media.98 In addition, mod-
iﬁcation of this 3D self-assembled peptide scaﬀold,
generated by forming a composite material with hy-
droxyapatite and encapsulation of EB-derived cells,
further enhanced mineralization compared to non-
composite peptide scaﬀolds.99 Consistent with this,
nanoﬁbrous scaﬀolds of poly(L-lactic acid) were
demonstrated to induce mouse EB-derived cells to
diﬀerentiate with enhanced expression of osteogenic
markers and increased calcium mineralization com-
pared to culture on thin ﬁlm scaﬀolds of the same
material (Figure 3D).100 It should be noted that each
of these studies employed EB formation to induce
ESC diﬀerentiation prior to seeding. An alternative
approach to induce diﬀerentiation employed electrical
stimulation of hESCs via a ﬁbronectin-coated gold
nanoparticle layer on tissue culture plastic with a
resultant loss of stem cell marker OCT-4 expression
and enhanced expression of osteogenic markers col-
lagen type I and Cbfa1 in contrast to unstimulated
cells.101 Following initial adhesion, mESCs seeded onto
a 3D poly(L-lactic acid) nanoﬁber matrix scaﬀold dis-
played greater interaction with the scaﬀold via ex-
tended processes than mESCs on a 2D poly(L-lactic
acid) nanoﬁber ﬁlm. Following diﬀerentiation on these
nanomaterials, in the presence of osteogenic media,
enhanced expression of osteogenic markers was de-
tected in cells cultured on 3D nanoﬁber scaﬀolds
compared to 2D nanoﬁber ﬁlms or gelatin-coated
tissue culture plastic. Furthermore, cells grown on 3D
nanoﬁber scaﬀolds displayed reduced expression of
neural markers, suggesting that diﬀerentiation was
directed toward an osteogenic lineage as opposed to
general diﬀerentiation toward nonspeciﬁc lineages.102
Similarly, Farzaneh et al. reported enhanced function-
ality of hESC-derived hepatocyte cells when hESCs
were diﬀerentiated on Ultra-Web with stepwise
introduction of chemical diﬀerentiation factors.103
Endodermal diﬀerentiation was also enhanced in
mouse iPSCs cultured on graphene-oxide-coated glass
surfaces in the absence of LIF, although expression
of ectodermal and mesodermal markers was also
detected.69 Interestingly, Chen and co-workers re-
ported mouse iPSCs to exhibit rapid proliferation
on graphene oxide with outgrowth of colonies in
contrast to graphene-coated glass or uncoated glass
surfaces.69 In contrast, a reduced capacity for
endodermal diﬀerentiation was reported following
incubation of mESCs on a surface formed from
400 nm diameter silica colloidal crystal microspheres
in comparison to mESCs on ﬂat glass or EB diﬀerentia-
tion was reported.68
Recently, we have described a polycarbonate
nanotopography surface that promotes hESC diﬀeren-
tiation toward cell types with both expression and
epigenetic characteristics akin to fetal skeletal stem
cells (Figure 4).104,105 Markers of skeletal stem cells
(STRO-1, CD44, CD63, ALCAM) were detectable in
diﬀerentiated ESCs following culture on nanotopogra-
phical surfaces displaying a near square arrangement
of 120 nm diameter nanopits (300 nm centercenter
spacing randomly displaced by <50 nm on x and y
axes) (Figure 4). Moreover, neural markers were un-
detectable at either the RNA or protein level, providing
suﬃcient evidence of eﬃcient directed diﬀerentiation
Figure 4. Nanoscale surface topography directs stem cell diﬀerentiation. In a basal media lacking soluble diﬀerentiation-
directing factors, hESC seededonto polycarbonate substrates displaying 120nmdiameter nanopits arranged in a near square
geometry (300 nm centercenter spacing displaced by 50 nmon x and y axes) diﬀerentiate toward amesodemal lineagewith
enhanced expression of skeletal stem cell marker STRO-1 (green). Cells are counterstained with nuclear stain DAPI (blue)
(scale bar 50 μm). Reprinted from ref 104. Copyright 2013 Wiley-VCH.
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by a deﬁned nanotopography surface104,105 and with
potential applications therein in orthopedic tissue
engineering and regenerative medicine.
In Vivo Nanomaterial Scaffold. Typical approaches
to investigate ESC differentiation-inducing nanomate-
rials have investigated in vitro scaffold-type induction.
However, it is also appropriate to consider nanomate-
rials that can be co-transplanted with ESCs for
therapeutic use. In vivo use of nanomaterials was
elegantly demonstrated by Davis et al., who reported
the co-injection of self-assembling peptide nanofibers
and mESCs into the left ventricle of adult mice. The
mESCs were shown to survive and spontaneously
differentiate within this environment.106
These studies reveal the eﬃcacy of nanomaterial
scaﬀolds in the induction of ESC diﬀerentiation to a
variety of cell types. However, comparability to termi-
nally diﬀerentiated cell types, as evidenced by full
functionality (including in vivo functionality following
transplant), as opposed tomarker expression and long-
term viability remains to be demonstrated. Addition-
ally, and critically for future clinical applications, the
absence of residual undiﬀerentiated cell types is scar-
cely described. While the few cell types reported to
be derived from ESCs using nanomaterials are clinically
relevant, with over 200 distinct cell types known
to comprise the human body, signiﬁcant challenges
lay ahead before every adult human cell can be made
available for regenerative medicine applications.
Future Directions;Challenges and Opportunities. Given
the self-renewal potential of ESCs and iPSCs and a
need to obtain sufficient differentiated populations for
transplantation, it is evident that strategies maintain-
ing an undifferentiated stem cell state during large-
scale expansion (without spontaneous differentiation)
will be crucial. Such approaches, alongside the poten-
tial of nanotopography to modulate ESC aggregation
and to mimic the ESC niche, remain to be investigated
in depth. Within this niche, ESCs may form a micro-
environment supportive of self-renewal, a process
which has been shown to favor the maintenance of
pluripotency of mESCs and hESCs.107,108 Coupled with
a growing understanding of the stem cell nano-niche,
it is possible that nanoscaffolds could be developed to
scale-up hESC expansion, thus providing a potentially
unlimited source of ESCs, although maintenance of
self-renewal and retention of pluripotency throughout
such a mass expansion procedure will need to be
confirmed and monitored.
Currently, there is a paucity of information as to
how ESCs sense their nanoenvironments and the
mechanisms by which this alters cell fate. The nano-
mechanical properties of tissues can be investigated
by measuring hardness and elastic modulus using
nanoindentation techniques. Charitidis compared the
nanomechanical properties of bone and cartilage and
highlighted that nanoindentation investigations are
largely hampered by the water content of tissues, cells,
and the ex vivo environment.109 In addition, the repro-
ducibility of results was reported to be variable and
dependent on the geometry and composition of the
indentation tip selected, on the depth of indentation,
and on the calibration materials implemented. How-
ever, nanoscale mechanical changes are known to be
an important factor in protein biology, in particular, the
tensile properties of intermediate ﬁlaments. Qin et al.
reported that vimentin undergoes an R-helix to a
β-sheet conformational change under strain and sug-
gested that this may oﬀer a protective mechanism to
the cell cytoplasm in resisting large deformation.110
However, Rho-associated kinase phosphorylation
of vimentin is reported to regulate agonist-mediated
neurite retraction,111 coupling vimentin with cell mor-
phology response. Integrin-mediated focal adhesions
and E-cadherin (which binds components of the
cytoskeleton) were reported to regulate cellular sen-
sing of topographical cues in hESCs.75 Consistent with
these observations, Sun and colleagues describe roles
for focal adhesion formation and E-cadherin in me-
chanoresponsive diﬀerentiation and cytoskeleton
contractility.31 (Mechanotransduction and mechanical
control of stem cell fate is reviewed by Sun et al.32 and
references therein.)
It is conceivable that tension would be altered by
cell adhesion to a topographical surface. Tensile forces
provided by cell-cortex tension in zebraﬁsh embryos
have been shown to direct progenitor cell sorting in a
manner that is both actomyosin-dependent and
nodal/transforming growth factor β (TGF-β) signaling-
dependent.112 To this end, relatively little information
is available regarding the signaling pathways activated
or inactivated and translational mechanisms following
ESC/iPSC attachment to nanomaterials. Our recently
published work on bone-marrow-derived adult
skeletal stem cells may oﬀer an insight into stem cell
nano-niche sensing. We reported that disruption of
actinmyosin interaction and resulting loss of tension
disrupted the ability of a square arrangement of nano-
pits to support adult skeletal stem cell multipotency and
induced adipogenic diﬀerentiation.30 ERK signaling was
also implicated in nanotopographical maintenance and
directed diﬀerentiation of adult skeletal stem cells30
Moreover, ERK signaling has previously been impli-
cated in mESC diﬀerentiation63,64,113,114 in hESC self-
renewal115 and in mechanotransduction.116 We postu-
lated a role for small untranslated RNAs, which can mod-
ulate mRNA transcripts, thus yielding post-translational
control as a mechanism for nanotopography-induced re-
gulation of cell fate. Speciﬁcally, we observed an up-
regulation of C/D box snoRNAs (SNORDs) in adult skeletal
stem cells seeded on a square arrangement of nanopits in
comparison to a near square (displaced by 50 nm)
arrangement.30 These small RNA have been implicated
in stem cell pluripotency and diﬀerentiation.117,118
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Fine tuning of the nanomaterial or nanotopography
may be guided by current knowledge of ESC biology
since intracellular signaling pathways, proteomics, and
genomics underlying the maintenance of self-renewal,
lineage commitment, and directed diﬀerentiation un-
der typical culture conditions or soluble factor-induced
diﬀerentiation are, in comparison, well-deﬁned for
bothmESCs and hESCs. Our recent work oﬀers possible
clues as to the pattern order and disorder within a
biomiometic physiological context. We have pre-
viously highlighted diﬀerential control of cell fate from
a nonbiomimetic state of absolute order to a biological
level of nano-order (i.e., displacement of nanopits from
an ordered square to a near square arrangement by
displacement of 50 nm) that results in a switch from
maintenance of the adult skeletal stem cell state
to directed osteogenic diﬀerentiation.30,119 Whether
the same phenomenon exists in pluripotent cells is
currently under investigation within our laboratory.
Furthermore, there exists an untapped potential to
generate scaﬀolds with select nanotopographical cues
for directed diﬀerentiation. This would build on the
studies of Unadkat et al.,120 providing improved sur-
faces with better diﬀerentiation directing eﬃciency of
ESCs and iPSCs for tissue formation both ex vivo and
in vivo. Moreover, future developments in cell defor-
mation and cytoskeletal component nanomechanics
may assist in expanding our understanding of how
cells sense their nano-niche.
While ESCs provide a satisfactory alternative to
adult stem cells, patient-speciﬁc iPSC-derived cell
types may further overcome ethical and immune
rejection issues. However, the challenges faced in
bringing iPSC-derived cells and patient-speciﬁc strate-
gies using iPSC-derived cells into clinical use are likely
to be similar to those for using hESC-derived cell types
as therapies with the additional challenge of optimiz-
ing a high-throughput method for eﬃcient, homo-
geneous reprogramming of a patient's somatic cell
sample.17,18 Since iPSCs have a growing number of
reported diﬀerences to ESCs, it is important that iPSCs
continue to be investigated alongside ESCs. If these
diﬀerences are not detrimental to therapeutic poten-
tial, iPSCs could indeed be used to generate patient-
speciﬁc regenerated tissues for therapy.16 High-
eﬃciency, viral-free methods for gene transfer are
extremely desirable for both cell-based therapies and
reprogramming of somatic cells to iPSCs. A number of
reports claim to have improved the transfer of genetic
material into cells using nanoparticles; however, the
full extent of the long-term eﬀects, accumulation,
and genotoxicity of nanoparticles in transplanted cells
(and systemically in patients) remains to be clariﬁed.
Furthermore, other nanomaterials may pose toxicity
risks. This has already been shown for multiwalled
carbon nanotubes. DNA damage was reported in
mESCs, in the form of enhanced p53 expression and
increased expression of double-strand break repair
proteins, detectable within 4 h of exposure.121 In
addition, single-walled carbon nanotubes were re-
ported to induce early miscarriages and fetal malfor-
mations following exposure in female mice together
with indications of embryotoxicity in mESCs.122 How-
ever, more focus has recently been placed on improv-
ing the biocompatibility and reducing the toxicity of
nanotubes formedical applications (reviewedby Bianco
and colleagues in ref 123 and references therein).
Eﬃcient production of functionally stable ESC/iPSC-
derived cell types remains a signiﬁcant challenge to
regenerative medicine. Moreover, for transplantation,
ESC/iPSC-derived cell types need to be comparable to
their endogenous counterparts. Recently, a diﬀerential
capacity for ESC-derived osteogenic cells and human
bone-marrow-derived osteogenic cells to deposit ma-
ture bone tissue in vivo was highlighted.124
ESC lines are known to display diﬀerences, as a
consequence of culture conditions, in genetic and
epigenetic stability and genetic variation.125 This di-
versity may also apply to the manner in which, and the
extent to which, nanomaterials may be able to manip-
ulate the fate of diﬀerent ESC lines. Furthermore, iPSC
research may reveal a similar problem in both patient-
to-patient variability as well as the somatic cell
type used to form iPSCs, which could in turn alter
their response to manipulation with nanomaterials.
Undoubtedly, ethical implications are likely to arise as
the medical use of nanotechnology and ESCs in com-
bination is realized.126 To date, reports deﬁning the
ﬁner moral and ethical details of this emerging area of
therapy remain limited.
CONCLUSION
Innovative nanotechnology platforms and novel
stem cell sources continue to enhance interest within
this area, in particular, the use of nanomaterials for the
investigation and medical applications of ESCs. Regen-
erative medicine as a whole faces a signiﬁcant chal-
lenge with multiple complexities given the diverse
range of tissue types within the human body: hard,
soft, contractible, electrically active, 2D layered, and 3D
architecture. Fortunately, nanomaterials oﬀer the pos-
sibility to form novel scaﬀolds, medical device surfaces,
and/or particles that can inﬂuence stem cell fate in an
already demonstrated diverse manner. Conceivably,
an ECM-mimicking approach, as has been used to
fabricate nanomaterials for adult stem or somatic cell
studies, will also prove useful for cellular expansion of
self-renewing, pluripotent ESCs. Designing a nanoscaf-
fold that creates an environment recapitulating in vivo
developmental progression or the transfer of genetic
material by nanoparticles, guided by our current un-
derstanding of ESC biology, may prove to be intuitive
approaches for eﬃcient directed diﬀerentiation.
Looking to the future, a fully collaborative approach
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between the disciplines of regenerative medicine,
stem cell biology, and nanotechnology will be most
beneﬁcial in deriving strategies for tissue augmenta-
tion and, ultimately, clinical beneﬁt.
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